EP Patent

EP0912535A1 — Conjugates of cis-docosahexaenoic acid and paclitaxel

Assigned to Protarga Inc · Expires 1999-05-06 · 27y expired

What this patent protects

The invention provides taxanes that are conjugates of cis-docosahexaenoic acid and paclitaxel. The conjugates are useful in treating cancer.

USPTO Abstract

The invention provides taxanes that are conjugates of cis-docosahexaenoic acid and paclitaxel. The conjugates are useful in treating cancer.

Drugs covered by this patent

Patent Metadata

Patent number: EP0912535A1
Jurisdiction: EP
Classification: —
Expires: 1999-05-06
Drug substance claim: No
Drug product claim: No
Assignee: Protarga Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.